RF
+
GLP-1 receptors and semaglutide agonists illustration
RF
+
GLP-1 receptors and semaglutide agonists illustration
RF
+
Inactivated GLP-1 receptor near semaglutide illustration
RF
+
GLP-1 receptor activated by semaglutide illustration
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Stylized skeletal formula (ch
RF
+
Saxagliptin diabetes drug molecule Inhibitor of dipeptidyl peptidase-4 (DPP4) Stylized skeletal formula (chemical structure) Atoms are shown as col
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as colo
RF
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Atoms are represented as sphe
ED
+
Januvia diabetes drug molecular model Januvia (sitagliptin) is a hypoglycaemic drug one that reduces blood sugar levels Diabetes is a condition in
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Atoms are represented as spheres with conventional colour coding hydro
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Atoms are represented as spheres with conventional colour coding hydro
RF
+
Linagliptin diabetes drug molecule
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Atoms are represented as spheres with conventional colour coding hydro
RF
+
Semaglutide diabetes drug molecule (incretin agonist) Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thi
RF
+
Semaglutide diabetes drug molecule (incretin agonist) White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Semaglutide diabetes drug molecule illustration
RF
+
Semaglutide diabetes drug molecule (incretin agonist) Blue skeletal formula on white background
RF
+
Lixisenatide diabetes drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles with thick black outlines
RF
+
Lixisenatide diabetes drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles connected by thin bonds o
RF
+
Liraglutide diabetes and obesity drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick blac
RF
+
Liraglutide diabetes and obesity drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Liraglutide diabetes and obesity drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by th
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as colo
RF
+
Liraglutide diabetes and obesity drug molecule illustration
RF
+
Linagliptin diabetes drug molecule illustration
RF
+
Linagliptin diabetes drug molecule illustration
RF
+
Linagliptin diabetes drug molecule illustration
RF
+
Exenatide diabetes drug molecule illustration
RF
+
Exenatide diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by thin bonds on a
RF
+
Exenatide diabetes drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Exenatide diabetes drug molecule Blue skeletal formula on white background
RM
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Stylized skeletal formula (ch
RM
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines White skeletal formula on dar
RM
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Stylized skeletal formula (ch
RM
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Blue skeletal formula on whit
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Lixisenatide diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles hydrogen (hidden) carbon
43
0
https://www.afloimages.com/search/incretins.html